Article
Multiomic study of cutaneous T-cell lymphoma reveals single-cell clonal evolution in progression and therapy resistance.
Blood - 21 May 2026
Dorando Hannah K, Andrews Jared M, Khatavkar Oam U, Borcherding Nicholas C, Korshunova Yulia, Hakeman Gabriela, Panigassi Rodrigo, Vo Phuong, Tu Ruei-Yuan, Tran Diep, Quinn Chaz C, Schmidt Jennifer A, Aluri Jahnavi, Harmon Michael T, Watkins Marcus P, Frank Anastasia, Cooper Megan A, Musiek Amy C, Mehta-Shah Neha, Payton Jacqueline E
Abstract excerpt
ABSTRACT: Cutaneous T-cell lymphoma (CTCL) remains a challenging disease due to its significant heterogeneity, therapy resistance, and relentless progression. Multiomics technologies offer the potential to provide uniquely precise views of disease progression and response to therapy. Here, we present a comprehensive multiomics view of CTCL clonal evolution, incorporating exome, whole-genome, epigenome, bulk,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
